Use of statins and risk of fractures.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2001-04-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.285.14.1850PMID 11308398
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Statins and the risk of dementia].

  2001cited by this paper
• Falls as Risk Factors for Fractures

  2001cited by this paper
• Use of Inhaled Corticosteroids and Risk of Fractures

  2001cited by this paper
• HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.

  2000cited by this paper
• Use of Oral Corticosteroids and Risk of Fractures

  2000cited by this paper
• Statins and the risk of dementia.

  2000cited by this paper
• The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results

  2000cited by this paper
• HMG-CoA reductase inhibitors and the risk of fractures.

  2000cited by this paper
• Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.

  2000cited by this paper
• Fall-induced injuries and deaths among older adults.

  1999cited by this paper
• Increasing number and incidence of fall-induced severe head injuries in older adults: nationwide statistics in Finland in 1970-1995 and prediction for the future.

  1999cited by this paper
• New insights into the pharmacodynamic and pharmacokinetic properties of statins.

  1999cited by this paper
• The Role of Geranylgeranylation in Bone Resorption and Its Suppression by Bisphosphonates in Fetal Bone Explants In Vitro: A Clue to the Mechanism of Action of Nitrogen‐Containing Bisphosphonates

  1999cited by this paper
• Stimulation of bone formation in vitro and in rodents by statins.

  1999cited by this paper
• Statistical Issues in Drug Development

  1999cited by this paper
• Hip fracture incidence and mortality in an English Region: a study using routine National Health Service data.

  1998cited by this paper
• The UK General Practice Research Database.

  1997cited by this paper
• Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

  1995cited by this paper
• The VAMP Research multi-purpose database in the U.K.

  1995cited by this paper
• A multifactorial intervention to reduce the risk of falling among elderly people living in the community.

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• The quality of information recorded on a UK database of primary care records: A study of hospitalizations due to hypoglycemia and other conditions

  1994cited by this paper
• Accuracy of diagnosis of psychosis on general practice computer system.

  1993cited by this paper
• Further validation of information recorded on a general practitioner based computerized data resource in the united kingdom

  1992cited by this paper
• Pharmacoepidemiology using a UK database of primary care records

  1992cited by this paper
• Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.

  1991cited by this paper
• Applied Regression Analysis and Other Multivariate Methods

  1978cited by this paper

• The study of total hip arthroplasty outcomes among statin users in Sina Hospital, Iran

  2025cites this paper
• Different Statin Dosages and Their Effects on Osteoporosis

  2024cites this paper
• Advantages of statin usage in preventing fractures for men over 50 in the United States: National Health and Nutrition Examination Survey

  2024cites this paper
• Statin use in patients with type 2 diabetes has lower risk of hip fractures: A Taiwan national population‐based study

  2022cites this paper
• Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18

  2022cites this paper
• Facts and ideas on statins with respect to their lipophilicity: a focus on skeletal muscle cells and bone besides known cardioprotection

  2022cites this paper
• Statin Therapy and the Risk of Osteoporotic Fractures in Patients with Metabolic Syndrome: a Nested Case-Control Study

  2021cites this paper
• Molecular enhancement of fracture healing - Is there a role for bone Morphogenetic Protein-2, Parathyroid Hormone, statins, or sclerostin-antibodies?

  2021cites this paper
• Statin use and risk of joint replacement due to osteoarthritis and rheumatoid arthritis: a propensity-score matched longitudinal cohort study.

  2020cites this paper
• Atorvastatin promotes bone formation in aged apoE–/– mice through the Sirt1–Runx2 axis

  2020cites this paper
• Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease

  2019cites this paper
• Effects of Statins on Relative Risk of Fractures for Older Adults: An Updated Systematic Review With Meta-Analysis.

  2019cites this paper
• Diagnosis of osteoporosis in statin-treated patients is dose-dependent

  2019cites this paper
• Association between osteoporosis and statins therapy: the story continues

  2019cites this paper
• Limitations for health research with restricted data collection from UK primary care

  2019cites this paper
• Association between osteoporosis and statins therapy

  2019cites this paper
• Case-control study examining the association between hip fracture risk and statins therapy in old people

  2019cites this paper
• Gender differences in cardiovascular disease

  2019cites this paper
• The Influence of Statins on Bone Tissue in Ovariectomized Rats

  2018cites this paper
• Error in Author Affiliation.

  2018cites this paper
• Mandibular Implant Prostheses

  2018cites this paper
• High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study

  2018cites this paper
• Improving Reporting Quality in Ophthalmologic Observational Studies That Use Big Data: The Case of Retinal Detachment Associated With Fluoroquinolone Use.

  2018cites this paper
• The effect of HMG-CoA reductase inhibitor (lovastatin) on bone mineral density (BMD) in postmenopausal women with type 2 diabetes

  2018cites this paper
• Improving reproducibility by using high-throughput observational studies with empirical calibration

  2018cites this paper
• Pharmacoepidemiological approaches for population-based hypothesis testing

  2018cites this paper
• Pharmacological Risk Assessment for Dental Implants

  2018cites this paper
• Role of Bone Morphogenetic Protein 2 Polymorphisms in Bone Mineral Density after the Start of Treatment with Atorvastatin

  2018cites this paper
• Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: Variation by age, sex, geographic location and ethnicity.

  2017cites this paper
• Statin use and hip fractures in U.S. kidney transplant recipients

  2017cites this paper
• [Effect of drugs for osteoporosis on cardiovascular diseases and effect of cardio vascular drugs on osteoporosis].

  2017cites this paper
• Statins and Risk of Lower Limb Revision Surgery: The Influence of Differences in Study Design Using Electronic Health Records From the United Kingdom and Denmark

  2016cites this paper
• Effects of Non-Steroidal Anti-Inflammatory Drugs on the Gastrointestinal and Cardiovascular System

  2016cites this paper
• Poly(l-Lactic Acid)/Gelatin Fibrous Scaffold Loaded with Simvastatin/Beta-Cyclodextrin-Modified Hydroxyapatite Inclusion Complex for Bone Tissue Regeneration.

  2016cites this paper
• The IMI PROTECT project: purpose, organizational structure, and procedures

  2016cites this paper
• Efficacy of statins for osteoporosis: a systematic review and meta-analysis

  2016cites this paper
• Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT‐EU project

  2016cites this paper
• Implications of immortal person-time when outcomes are nonfatal.

  2016cites this paper
• Effects of Statins on Bone Mineral Density and Fracture Risk

  2016cites this paper
• Statins and hip fracture risk in men: a population-based case-control study.

  2015cites this paper
• Statin use and risk of fracture: a meta-analysis.

  2015cites this paper
• Impact of antibiotic exposure on the risk of colorectal cancer

  2015cites this paper
• [Immortal time bias in pharmacoepidemiological studies: definition, solutions and examples].

  2015cites this paper
• Diabetes and bone: biological and environmental factors

  2015cites this paper
• Predictors of Mortality Subsequent to a Fracture in Diabetes Mellitus Patients

  2015cites this paper
• Statin therapy and risk of fracture: results from the JUPITER randomized clinical trial.

  2015cites this paper
• Editorial: harmonization in pharmacoepidemiological studies: (twi)light at the end of the tunnel?

  2014cites this paper
• Statins and osteoporosis: a latent promise.

  2014cites this paper
• Pharmacovigilance: The conscientious today for safe tomorrow

  2014cites this paper
• Digoxin use and the risk for colorectal cancer

  2014cites this paper
• High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: a population-based study

  2014cites this paper
• Efecto de la atorvastatina en el tratamiento de la periodontitis crónica moderada

  2014cites this paper
• Association of Statins and Risk of Fractures in a Military Health System

  2014cites this paper
• A REVIEW ON ROLE OF STATINS IN CLINICAL PRACTICE

  2014cites this paper
• Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis

  2014cites this paper
• Bridging Differences in Outcomes of Pharmacoepidemiological Studies: Design and First Results of the PROTECT Project

  2014cites this paper
• Complications of hip and knee replacement surgery: a pharmaco-epidemiological approach

  2014cites this paper
• Statins, bone metabolism and treatment of bone catabolic diseases.

  2014cites this paper
• Deneysel fare femur kaynamama modelinde lokal uygulanan simvastatinin etkileri

  2014cites this paper
• The effects of locally applied simvastatin on an experimental mouse femur nonunion model.

  2014cites this paper
• Effects of atorvastatin on bone mineral density (BMD) and bone metabolism in elderly males with osteopenia and mild dyslipidemia: a 1-year randomized trial.

  2014cites this paper
• Statins and osteoporosis: A latent promise

  2014cites this paper
• Enhanced in vitro osteoblast differentiation on TiO2 scaffold coated with alginate hydrogel containing simvastatin

  2013cites this paper
• Statin Use and Fracture Risk: Can We Quantify the Healthy-User Effect?

  2013cites this paper
• Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies

  2013cites this paper
• Update on statins: hope for osteoporotic fracture healing treatment.

  2013cites this paper
• Local delivery of controlled-release simvastatin/PLGA/HAp microspheres enhances bone repair

  2013cites this paper
• EFFECTS OF SIMVASTATIN ON FEMORAL BIOMECHANICS IN OVARIECTOMIZED RATS

  2013cites this paper
• Simvastatin enhances human osteoblast proliferation involved in mitochondrial energy generation.

  2013cites this paper
• Desideratum for Evidence Based Epidemiology

  2013cites this paper
• Development of the novel bone augmentation technique and bone substitute materials

  2013cites this paper
• Statin Use and Clinical Osteoarthritis in the General Population: A Longitudinal Study

  2013cites this paper
• Simvastatin local drug delivery in smokers with chronic periodontitis: a randomized controlled clinical trial.

  2013cites this paper
• Efficacy of subgingivally delivered simvastatin in the treatment of patients with type 2 diabetes and chronic periodontitis: a randomized double-masked controlled clinical trial.

  2013cites this paper
• Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD)

  2013cites this paper
• Effects of commonly used medications on bone tissue mineralisation in SaOS-2 human bone cell line: an in vitro study.

  2013cites this paper
• Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus

  2013cites this paper
• REVIEWS: CURRENT TOPICS Mevalonate-suppressive dietary isoprenoids for bone health

  2012cites this paper
• [Cardiovascular disease, osteoporosis and risk of fracture].

  2012cites this paper
• The Pleiotropic Effects of HMG-CoA Reductase Inhibitors

  2012cites this paper
• Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?

  2012cites this paper
• Statins and Menopause

  2012cites this paper
• Effects of Tocotrienol and Lovastatin Combination on Osteoblast and Osteoclast Activity in Estrogen-Deficient Osteoporosis

  2012influential citation
• Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer

  2012cites this paper
• Medical Therapies: Statins

  2012cites this paper
• The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database.

  2012cites this paper
• Mevalonate-suppressive dietary isoprenoids for bone health.

  2012cites this paper
• The Risk of Fracture in Patients With Multiple Sclerosis: The UK General Practice Research Database

  2011cites this paper
• Bisphosphonates and esophageal cancer—a pathway through the confusion

  2011cites this paper
• ANTI-DIABETIC TREATMENT AND CANCER OCCURRENCE AMONG PATIENTS WITH TYPE II DIABETES MELLITUS

  2011influential citation
• Simvastatin protects human osteosarcoma cells from oxidative stress-induced apoptosis through mitochondrial-mediated signaling.

  2011cites this paper
• MEVALONATE PATHWAY: ROLE OF BISPHOSPHONATES AND STATINS

  2011cites this paper
• Fluvastatin increases bone mineral density in postmenopausal women.

  2011cites this paper
• Cardiovascular disease and bone metabolism

  2011cites this paper
• [Cardiovascular disease and bone metabolism].

  2011cites this paper
• Enfermedad cardiovascular y metabolismo seo

  2011cites this paper
• Enfermedad cardiovascular y metabolismo óseo

  2011cites this paper
• New approaches to strengthen pharmacovigilance.

  2011cites this paper
• Evaluation and discrimination of simvastatin-induced structural alterations in proteins of different rat tissues by FTIR spectroscopy and neural network analysis.

  2010cites this paper
• Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countries.

  2010cites this paper